Statin response may be caused by genetics

Statin response may be genetically determined, a research team from Tayside has reported.

Genetic subgroups may need to be started on aggressive high-dose statin therapy to reach recommended lipid reduction targets, suggested Dr Colin Palmer, senior lecturer in the Biomedical Research Centre at Ninewells Hospital in Dundee, at the conference.

Carriers of gene variants known to affect lipid metabolism might fail to achieve recommended levels on standard therapy, Dr Palmer told the Primary Care Genetics Society conference.

Three-quarters of diabetes patients the apolipoprotein E4 (apoE4) allele never reached an LDL-cholesterol of <2mmol/l, the Tayside Go-DARTS study showed.

The apoE4 carriers' LDL-cholesterol dropped less significantly and post-treatment levels remained higher than in diabetics not carrying the apoE4 variant.

But Dr Palmer found that over 57 per cent of diabetics without the apoE4 allele did reach the recommended level.

'The apoE4 gene variant effect was most pronounced in individuals who were only mildly dyslipidaemic,' Dr Palmer said.

His team looked at 28 post-treatment lipid measurements from 953 diabetics who took statins over the 10-year period to May 2003.

ApoE4 defects result in increased plasma cholesterol due to impaired clearance of chylomicron and VLDL remnants.

The Tayside apoE4 carriers failed to reach recommended levels regardless of their baseline LDL, the researchers found.

prisca.middlemiss@haymarket.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs should carry out 45% of consultations remotely after pandemic, says Hancock

GPs should carry out 45% of consultations remotely after pandemic, says Hancock

Nearly half of GP consultations should continue to be delivered remotely after the...

Lockdown exit risks magnifying ‘incredible pressure’ on doctors, BMA warns

Lockdown exit risks magnifying ‘incredible pressure’ on doctors, BMA warns

The government’s plan to exit the national lockdown is ‘full of risks’ and could...

New GMC guidance on consent explained

New GMC guidance on consent explained

MDU medico-legal adviser Dr Kathryn Leask uses a series of case examples to explain...

Which COVID-19 vaccines are lined up for roll-out on the NHS?

Which COVID-19 vaccines are lined up for roll-out on the NHS?

As GPs and their teams prepare for delivering a COVID-19 vaccination programme that...

BAME doctors face COVID 'double hit' as pandemic drives rise in complaints

BAME doctors face COVID 'double hit' as pandemic drives rise in complaints

Black, asian and minority ethnic (BAME) doctors face a 'double hit' from COVID-19...

Practices can use £150m COVID fund to hire locum GPs, BMA confirms

Practices can use £150m COVID fund to hire locum GPs, BMA confirms

GP practices in England can use their share of a £150m COVID capacity fund to hire...